Abstract
Background/Aims: Large population-based studies are needed to assess the epidemiology and survival risk factors associated with pediatric brainstem gliomas. This retrospective study explores factors that may influence survival in this population. Methods: Utilizing the SEER database, the authors retrospectively assessed survival in histologically confirmed brainstem gliomas in patients aged 17 and younger. Survival was described with Kaplan-Meyer curves and multivariate regression analysis. Results: This analysis of 180 cases showed that age (hazard ratio [HR] 1.04, 95% CI 0.96–1.14, p = 0.34), non-white race (HR 1.00, 95% CI 0.35–2.85 p > 0.99), distant or invasive extension of the tumor (HR 0.4, 95% CI 0.08–2.53, p = 0.37), and radiation therapy (HR 1.27, 95% CI 0.52–3.11, p = 0.61) were not associated with decreased survival. High-grade tumor status (HR 8.64, 95% CI 3.49–21.41, p < 0.001) was associated with decreased survival. Partial resection (HR 0.11, 95% CI 0.04–0.30, p < 0.001) and gross-total resection (HR 0.03, 95% CI 0.01–0.14, p < 0.001) were associated with improved survival. Conclusions: High-grade brainstem gliomas have a worse prognosis. Early diagnosis and surgery appear to be associated with improved survival, while the role of radiation is unclear.
References
1.
Albright
AL
, Price
RA
, Guthkelch
AN
. Brain stem gliomas of children. A clinicopathological study
. Cancer
. 1983
Dec
;52
(12
):2313
–9
.
[PubMed]
0008-543X2.
Farwell
JR
, Dohrmann
GJ
, Flannery
JT
. Central nervous system tumors in children
. Cancer
. 1977
Dec
;40
(6
):3123
–32
.
[PubMed]
0008-543X3.
Freeman
CR
, Farmer
JP
. Pediatric brain stem gliomas: a review
. Int J Radiat Oncol Biol Phys
. 1998
Jan
;40
(2
):265
–71
.
[PubMed]
0360-30164.
Stiller
CA
. Population based survival rates for childhood cancer in Britain, 1980-91
. BMJ
. 1994
Dec
;309
(6969
):1612
–6
.
[PubMed]
0959-81385.
Walker
DA
, Punt
JA
, Sokal
M
. Clinical management of brain stem glioma
. Arch Dis Child
. 1999
Jun
;80
(6
):558
–64
.
[PubMed]
0003-98886.
Dolecek
TA
, Propp
JM
, Stroup
NE
, Kruchko
C
. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009
. [doi]
. Neuro-oncol
. 2012
Nov
;14
Suppl 5
:v1
–49
.
[PubMed]
1522-85177.
Jallo
GI
, Biser-Rohrbaugh
A
, Freed
D
. Brainstem gliomas
. Childs Nerv Syst
. 2004
Mar
;20
(3
):143
–53
.
[PubMed]
0256-70408.
Ueoka
DI
, Nogueira
J
, Campos
JC
, Maranhão Filho
P
, Ferman
S
, Lima
MA
. Brainstem gliomas—retrospective analysis of 86 patients
. J Neurol Sci
. 2009
Jun
;281
(1-2
):20
–3
.
[PubMed]
0022-510X9.
Guillamo
JS
, Monjour
A
, Taillandier
L
, Devaux
B
, Varlet
P
, Haie-Meder
C
, et al; Association des Neuro-Oncologues d’Expression Française (ANOCEF)
. Brainstem gliomas in adults: prognostic factors and classification
. Brain
. 2001
Dec
;124
(Pt 12
):2528
–39
.
[PubMed]
0006-895010.
Kaplan
AM
, Albright
AL
, Zimmerman
RA
, Rorke
LB
, Li
H
, Boyett
JM
, et al Brainstem gliomas in children. A Children’s Cancer Group review of 119 cases
. Pediatr Neurosurg
. 1996
;24
(4
):185
–92
.
[PubMed]
1016-229111.
Mauffrey
C
. Paediatric brainstem gliomas: prognostic factors and management
. J Clin Neurosci
. 2006
May
;13
(4
):431
–7
.
[PubMed]
0967-586812.
Sun
T
, Wan
W
, Wu
Z
, Zhang
J
, Zhang
L
. Clinical outcomes and natural history of pediatric brainstem tumors: with 33 cases follow-ups.
Neurosurg Rev. 2013
;36(2):311-9-20. 13.
Sandri
A
, Sardi
N
, Genitori
L
, Giordano
F
, Peretta
P
, Basso
ME
, et al Diffuse and focal brain stem tumors in childhood: prognostic factors and surgical outcome. Experience in a single institution
. Childs Nerv Syst
. 2006
Sep
;22
(9
):1127
–35
.
[PubMed]
0256-704014.
Teo
C
, Siu
TL
. Radical resection of focal brainstem gliomas: is it worth doing?
[doi]
. Childs Nerv Syst
. 2008
Nov
;24
(11
):1307
–14
.
[PubMed]
0256-704015.
Mehta
VS
, Chandra
PS
, Singh
PK
, Garg
A
, Rath
GK
. Surgical considerations for ‘intrinsic’ brainstem gliomas: proposal of a modification in classification
. Neurol India
. 2009
May-Jun
;57
(3
):274
–81
.
[PubMed]
0028-388616.
Halperin
EC
. Pediatric brain stem tumors: patterns of treatment failure and their implications for radiotherapy
. Int J Radiat Oncol Biol Phys
. 1985
Jul
;11
(7
):1293
–8
.
[PubMed]
0360-301617.
Mandell
LR
, Kadota
R
, Freeman
C
, Douglass
EC
, Fontanesi
J
, Cohen
ME
, et al There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy
. Int J Radiat Oncol Biol Phys
. 1999
Mar
;43
(5
):959
–64
.
[PubMed]
0360-301618.
Janssens
GO
, Gidding
CE
, Van Lindert
EJ
, Oldenburger
FR
, Erasmus
CE
, Schouten-Meeteren
AY
, et al The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study
. Int J Radiat Oncol Biol Phys
. 2009
Mar
;73
(3
):722
–6
.
[PubMed]
0360-301619.
Janssens
GO
, Jansen
MH
, Lauwers
SJ
, Nowak
PJ
, Oldenburger
FR
, Bouffet
E
, et al Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis
. Int J Radiat Oncol Biol Phys
. 2013
Feb
;85
(2
):315
–20
.
[PubMed]
0360-301620.
Zaghloul
MS
, Eldebawy
E
, Ahmed
S
, Mousa
AG
, Amin
A
, Refaat
A
, et al Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial
. Radiother Oncol
. 2014
Apr
;111
(1
):35
–40
.
[PubMed]
0167-814021.
Fuchs
I
, Kreil
W
, Sutter
B
, Papaethymiou
G
, Pendl
G
. Gamma Knife radiosurgery of brainstem gliomas
. Acta Neurochir Suppl
. 2002
;84
:85
–90
.
[PubMed]
0065-141922.
Raikar
SS
, Halloran
DR
, Elliot
M
, McHugh
M
, Patel
S
, Gauvain
KM
. Outcomes of pediatric low-grade gliomas treated with radiation therapy: a single-institution study
. J Pediatr Hematol Oncol
. 2014
Aug
;36
(6
):e366
–70
.
[PubMed]
1077-411423.
Louis
DN
, Perry
A
, Reifenberger
G
, von Deimling
A
, Figarella-Branger
D
, Cavenee
WK
, et al The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
. Acta Neuropathol
. 2016
Jun
;131
(6
):803
–20
.
[PubMed]
0001-632224.
Guillamo
JS
, Doz
F
, Delattre
JY
. Brain stem gliomas
. Curr Opin Neurol
. 2001
Dec
;14
(6
):711
–5
.
[PubMed]
1350-754025.
El-Ayadi
M
, Ansari
M
, Sturm
D
, Gielen
GH
, Warmuth-Metz
M
, Kramm
CM
, et al High-grade glioma in very young children: a rare and particular patient population
. Oncotarget
. 2017
Jun
;8
(38
):64564
–78
.
[PubMed]
1949-255326.
Karremann
M
, Gielen
GH
, Hoffmann
M
, Wiese
M
, Colditz
N
, Warmuth-Metz
M
, et al Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
. Neuro-oncol
. 2018
Jan
;20
(1
):123
–31
.
[PubMed]
1522-851727.
Ryall
S
, Krishnatry
R
, Arnoldo
A
, Buczkowicz
P
, Mistry
M
, Siddaway
R
, et al Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma
. Acta Neuropathol Commun
. 2016
Aug
;4
(1
):93
.
[PubMed]
2051-596028.
Khuong-Quang
DA
, Buczkowicz
P
, Rakopoulos
P
, Liu
XY
, Fontebasso
AM
, Bouffet
E
, et al K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
. Acta Neuropathol
. 2012
Sep
;124
(3
):439
–47
.
[PubMed]
0001-632229.
Buczkowicz
P
, Bartels
U
, Bouffet
E
, Becher
O
, Hawkins
C
. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications
. Acta Neuropathol
. 2014
Oct
;128
(4
):573
–81
.
[PubMed]
0001-632230.
Kramm
CM
, Wagner
S
, Van Gool
S
, Schmid
H
, Sträter
R
, Gnekow
A
, et al Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies
. Anticancer Res
. 2006
Sep-Oct
;26
5B
:3773
–9
.
[PubMed]
0250-700531.
Lapras
C
, Bognar
L
, Turjman
F
, Villanyi
E
, Mottolese
C
, Fischer
C
, et al Tectal plate gliomas. Part I: microsurgery of the tectal plate gliomas
. Acta Neurochir (Wien)
. 1994
;126
(2-4
):76
–83
.
[PubMed]
0001-626832.
Li
KW
, Roonprapunt
C
, Lawson
HC
, Abbott
IR
, Wisoff
J
, Epstein
F
, et al Endoscopic third ventriculostomy for hydrocephalus associated with tectal gliomas
. Neurosurg Focus
. 2005
Jun
;18
6A
:E2
.
[PubMed]
1092-068433.
Pollack
IF
, Pang
D
, Albright
AL
. The long-term outcome in children with late-onset aqueductal stenosis resulting from benign intrinsic tectal tumors
. J Neurosurg
. 1994
Apr
;80
(4
):681
–8
.
[PubMed]
0022-308534.
Wu
G
, Broniscer
A
, McEachron
TA
, Lu
C
, Paugh
BS
, Becksfort
J
, et al; St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project
. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
. Nat Genet
. 2012
Jan
;44
(3
):251
–3
.
[PubMed]
1061-403635.
Ronghe
M
, Hargrave
D
, Bartels
U
, Tabori
U
, Vaidya
S
, Chandler
C
, et al Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem
. Pediatr Blood Cancer
. 2010
Sep
;55
(3
):471
–7
.
[PubMed]
1545-500936.
Packer
RJ
, Lange
B
, Ater
J
, Nicholson
HS
, Allen
J
, Walker
R
, et al Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood
. J Clin Oncol
. 1993
May
;11
(5
):850
–6
.
[PubMed]
0732-183X37.
Massimino
M
, Spreafico
F
, Biassoni
V
, Simonetti
F
, Riva
D
, Trecate
G
, et al Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience
. J Neurooncol
. 2008
May
;87
(3
):355
–61
.
[PubMed]
0167-594X38.
Hargrave
D
, Bartels
U
, Bouffet
E
. Diffuse brainstem glioma in children: critical review of clinical trials
. Lancet Oncol
. 2006
Mar
;7
(3
):241
–8
.
[PubMed]
1470-204539.
Warren
KE
, Goldman
S
, Pollack
IF
, Fangusaro
J
, Schaiquevich
P
, Stewart
CF
, et al Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018
. J Clin Oncol
. 2011
Jan
;29
(3
):324
–9
.
[PubMed]
0732-183X40.
Robison
NJ
, Campigotto
F
, Chi
SN
, Manley
PE
, Turner
CD
, Zimmerman
MA
, et al A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
. Pediatr Blood Cancer
. 2014
Apr
;61
(4
):636
–42
.
[PubMed]
1545-500941.
Gururangan
S
, Fangusaro
J
, Poussaint
TY
, McLendon
RE
, Onar-Thomas
A
, Wu
S
, et al Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study
. Neuro-oncol
. 2014
Jan
;16
(2
):310
–7
.
[PubMed]
1522-851742.
Bailey
S
, Howman
A
, Wheatley
K
, Wherton
D
, Boota
N
, Pizer
B
, et al Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy—results of a United Kingdom phase II trial (CNS 2007 04)
. Eur J Cancer
. 2013
Dec
;49
(18
):3856
–62
.
[PubMed]
0959-804943.
Cohen
KJ
, Heideman
RL
, Zhou
T
, Holmes
EJ
, Lavey
RS
, Bouffet
E
, et al Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children’s Oncology Group
. Neuro-oncol
. 2011
Apr
;13
(4
):410
–6
.
[PubMed]
1522-851744.
Landolfi
JC
, Thaler
HT
, DeAngelis
LM
. Adult brainstem gliomas
. Neurology
. 1998
Oct
;51
(4
):1136
–9
.
[PubMed]
0028-387845.
Selvapandian
S
, Rajshekhar
V
, Chandy
MJ
. Brainstem glioma: comparative study of clinico-radiological presentation, pathology and outcome in children and adults.
Acta Neurochir (Wien). 1999
;141(7):721-6-7. © 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
